Guggenheim Capital LLC Balchem Corp Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Balchem Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 1,517 shares of BCPC stock, worth $242,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,517

Previous 1,981 23.42%

Holding current value

$242,659

Previous $304,000 12.5%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$154.1 - $181.56 $71,502 - $84,243	-464 Reduced 23.42%	1,517 $266,000
Q2 2024 Aug 14, 2024	SELL	$138.5 - $156.63 $40,026 - $45,266	-289 Reduced 12.73%	1,981 $304,000
Q1 2024 May 14, 2024	BUY	$137.06 - $157.27 $54,275 - $62,278	396 Added 21.13%	2,270 $351,000
Q4 2023 Feb 14, 2024	BUY	$115.08 - $150.35 $215,659 - $281,755	1,874 New	1,874 $278,000
Q4 2022 Feb 14, 2023	SELL	$120.16 - $142.73 $427,409 - $507,690	-3,557 Reduced 26.54%	9,846 $1.2 Million
Q3 2022 Nov 14, 2022	BUY	$119.7 - $141.48 $809,531 - $956,829	6,763 Added 101.85%	13,403 $1.63 Million
Q2 2022 Aug 15, 2022	BUY	$113.6 - $139.82 $71,568 - $88,086	630 Added 10.48%	6,640 $862,000
Q1 2022 May 16, 2022	BUY	$131.21 - $167.55 $262,288 - $334,932	1,999 Added 49.84%	6,010 $821,000
Q4 2021 Feb 14, 2022	BUY	$149.18 - $172.5 $598,360 - $691,897	4,011 New	4,011 $676,000
Q4 2020 Feb 16, 2021	SELL	$98.58 - $115.22 $328,074 - $383,452	-3,328 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$91.61 - $103.46 $86,388 - $97,562	943 Added 39.54%	3,328 $325,000
Q2 2020 Aug 14, 2020	SELL	$80.3 - $102.54 $2,409 - $3,076	-30 Reduced 1.24%	2,385 $226,000
Q1 2020 Jun 02, 2020	SELL	$81.49 - $113.6 $47,264 - $65,888	-580 Reduced 19.37%	2,415 $238,000
Q4 2019 Feb 14, 2020	SELL	$96.34 - $105.25 $8,670 - $9,472	-90 Reduced 2.92%	2,995 $304,000
Q3 2019 Nov 14, 2019	SELL	$83.01 - $105.34 $62,257 - $79,005	-750 Reduced 19.56%	3,085 $306,000
Q2 2019 Aug 14, 2019	SELL	$90.69 - $102.96 $17,412 - $19,768	-192 Reduced 4.77%	3,835 $383,000
Q1 2019 May 15, 2019	SELL	$76.21 - $95.45 $42,144 - $52,783	-553 Reduced 12.07%	4,027 $374,000
Q4 2018 Feb 14, 2019	SELL	$73.39 - $110.81 $14,531 - $21,940	-198 Reduced 4.14%	4,580 $359,000
Q3 2018 Nov 14, 2018	BUY	$97.22 - $116.69 $43,360 - $52,043	446 Added 10.3%	4,778 $536,000
Q2 2018 Aug 14, 2018	SELL	$80.7 - $100.4 $271,716 - $338,046	-3,367 Reduced 43.73%	4,332 $425,000
Q1 2018 May 15, 2018	SELL	$70.84 - $82.37 $298,378 - $346,942	-4,212 Reduced 35.36%	7,699 $629,000
Q4 2017 Feb 14, 2018	SELL	$79.39 - $87.71 $971,812 - $1.07 Million	-12,241 Reduced 50.68%	11,911 $959,000
Q3 2017 Nov 14, 2017	BUY	$73.12 - $81.91 $1.77 Million - $1.98 Million	24,152	24,152 $1.96 Million

Others Institutions Holding BCPC

# of Institutions

372

Shares Held

28.3M

Call Options Held

267K

Put Options Held

5.7K

View Full List

About BALCHEM CORP

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $5.14B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

More about BCPC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Balchem Corp Transaction History